Detalhe da pesquisa
1.
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trials.
Cancer
; 130(3): 439-452, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795845
2.
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma.
Invest New Drugs
; 42(2): 179-184, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38372949
3.
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682560
4.
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).
Cancer
; 127(13): 2204-2212, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765337
5.
A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors.
Invest New Drugs
; 35(3): 290-297, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28004284
6.
A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin E 2,2,5,7,8-pentamethyl-6-chromanol (APC-100) in men with advanced prostate cancer.
Invest New Drugs
; 34(2): 225-30, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26924129
7.
PARP inhibitors in metastatic prostate cancer.
Front Oncol
; 13: 1159557, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37168382
8.
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer.
J Immunother Cancer
; 11(12)2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101860
9.
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE).
Mol Cancer Ther
; 22(4): 511-518, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780008
10.
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer.
Clin Cancer Res
; 29(12): 2324-2335, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939530
11.
Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials.
Cancer Epidemiol Biomarkers Prev
; 32(11): 1552-1557, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410096
12.
Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC).
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277461
13.
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.
Clin Genitourin Cancer
; 20(1): 1-10, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34364796
14.
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma.
J Clin Oncol
; 40(31): 3633-3641, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617646
15.
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer.
J Clin Invest
; 132(21)2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317634
16.
A case of metastatic renal cell carcinoma with concomitant Castleman's disease treated with immunotherapy.
Urol Case Rep
; 38: 101720, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34094876
17.
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.
J Clin Oncol
; 39(22): 2474-2485, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33929895
18.
Polycystic Liver Disease in a Patient With Metastatic Renal Cell Carcinoma: A Case Report.
Anticancer Res
; 40(3): 1527-1534, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32132053
19.
Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer.
Clin Cancer Res
; 26(19): 5162-5171, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513836
20.
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE).
J Clin Oncol
; 38(36): 4240-4248, 2020 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33108238